Cengild Medical Berhad (0243.KL)
Kuala Lumpur · MYR · Healthcare · Medical Care Facilities
MYR 0.16 (+0.00%) as of
Key statistics
- Market cap
- 133.27M
- P/E (TTM)
- 16.00
- EPS (TTM)
- 0.0100
- Dividend yield
- 0.39%
- 52-week range
- 0.1300 – 0.2500
- Beta
- 0.09
- Revenue (TTM)
- 73.21M
- Profit margin
- 15.63%
About Cengild Medical Berhad
Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiology; ear, nose and throat; gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric surgery; and chemotherapy. It also provides medical management services; nursing services and clinical support services; clinical laboratory and pharmacy; operating theatre, endoscopy, radiology and imaging services; accident and emergency care, and health screenings; and consultant services. Cengild Medical Berhad was founded in 2017 and is based in Kuala Lumpur, Malaysia.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Kuala Lumpur, Malaysia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.